+22 or trisomy 22 (solely?)
2000-02-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
acute myeloid leukemia (AML)
Phenotype stem cell origin
M4eo AML most often in cases associated with inv(16); M4 also, but only in 2/3 of cases ,when +22 is apparently without inv(16); and eosinophilia may be missing in the latter case
Epidemiology
young age, both in cases with or without inv(16)
Clinics
inv(16) may be at increased CNS relapse when +22 is also present
Prognosis
a fair prognosis is associated with +22 accompanying inv(16), and with +22 solely, comparable to the prognosis associated with inv(16)
Cytogenetics
Cytogenetics morphological
+22 is a frequent anomaly additional to inv(16), but was not found associated with other anomalies recurrently found in de novo AML; +22 may also occur apparently in the absence of inv(16), but cryptic rearrangements of MYH11 (16p13) and CBFB (16q22) have been found in a number of cases; for some authors, +22 indicates the obligate existence of an inv(16); for others +22 solely is a true entity
Cytogenetics molecular
is appropriate to exclude or discover the presence of a hidden inv(16), inasmuch as inv(16) is associated with a relatively good prognosis
Genes Involved and Proteins
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 2790767 | 1989 | Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16? | Grois N et al |
| 8207990 | 1994 | Secondary chromosomal abnormalities in acute leukemias. | Johansson B et al |
| 9609531 | 1998 | A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council. | Langabeer SE et al |
| 3465376 | 1986 | Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. | Larson RA et al |
| 3163744 | 1988 | Central nervous system involvement in acute nonlymphocytic leukemia with inv(16)(p13q22). | Ohyashiki K et al |
| 10087946 | 1999 | Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16. | Wong KF et al |
Summary
Note
+22 is often associated with inv(16)(p13q22) or its equivalents; the existence of trisomy 22 solely is debated
Citation
Jean-Loup Huret
+22 or trisomy 22 (solely?)
Atlas Genet Cytogenet Oncol Haematol. 2000-02-01
Online version: http://atlasgeneticsoncology.org/haematological/1042/+22-or-trisomy-22-(solely-)
